Introduction
Cancer Australia’s Priority-driven Collaborative Cancer Research Scheme is an annual national research project grant scheme which funds cancer research in identified priority areas to help reduce the impact of cancer in the community and improve outcomes for people affected by cancer.
Priority-driven Collaborative Cancer Research grants will support Australian researchers to work collaboratively to generate evidence, increase knowledge, and improve the translation of research into policy and practice in identified priority areas.
All applications for funding by Cancer Australia and its Funding Partners are to be submitted and reviewed through the NHMRC Project Grants funding scheme.
2012 Round of the Priority-driven Collaborative Cancer Research Scheme
This program is an initiative of Cancer Australia and involves the following funding partners in 2012:
- Australian Rotary Health,
- beyondblue, the national depression and anxiety initiative,
- Cancer Council Australia,
- Cancer Council New South Wales,
- Cure Cancer Australia Foundation,
- Leukaemia Foundation,
- National Breast Cancer Foundation, and
- Prostate Cancer Foundation of Australia.
The NHMRC is facilitating the registration and assessment of grant applications, and will endorse grants funded through the Priority-driven Collaborative Cancer Research Scheme.
The call for applications to the Priority-driven Collaborative Cancer Research Scheme opened on 23 December 2011 for 2012 closes at 5pm (AEDT) 14 March 2012. Researchers working in Australia are eligible to apply.
Three types of project grants are offered to support the conduct of cancer research in Australia. These are:
Funding Category A
- Project grants of up to three years duration, with funding available up to $600,000 (GST-exclusive), with a maximum in any one year of $200,000 (GST-exclusive) will be offered (alone or jointly) by Cancer Australia, beyondblue, Cancer Council Australia, Cancer Council New South Wales, Leukaemia Foundation, National Breast Cancer Foundation, and the Prostate Cancer Foundation Australia. All project grant applications ranging from 1 to 3 years within a budget ranging from $10,000 to $200,000 per annum will be considered by Cancer Australia and these funding partners;
Funding Category B
- Project grants of one year duration up to $100,000 (GST-exclusive) will be offered by the Cure Cancer Australia Foundation to support project grants by post-doctoral researchers with 1-3 years post-doctoral experience or 1-3 years post MBBS qualification undertaking a one year research project into malignant disease.
Funding Category C
- Project grants of up to 2 years duration for up to $200,000 (GST-exclusive) with a maximum in any one year of $100,000, will be offered by the Cure Cancer Australia Foundation to support project grants by post-doctoral researchers with 4-7 years post-doctoral experience or 4-7 years post MBBS qualification, undertaking a 1 to 2 year/s research project into malignant disease.
Cure Cancer Australia Foundation wishes to fund innovative, high-achieving, early-career researchers, and will be assessing the Track Record and Publications of the Chief Investigator submitted as part of the NHMRC application process to determine priority for these grants. Funding Categories B and C cannot be used to provide a salary or other support for a young investigator as part of a larger PdCCRS project grant application.
Grant applications must relate to the research priority areas identified by Cancer Australia and its funding partners.
The research priority areas for 2012 Round of the Priority-driven Collaborative Cancer Research Scheme can be found on the Cancer Australia website
For further information see the call for applications page on the Cancer Australia website.
Contact:
Dr Paul Jackson
Program Manager, Research, Cancer Australia: 02 6217 9810